trx000

$SGMO $XBI @US_FDA $ Biotech as it exists today will not have a place in our AI future. You won’t have 30 years old companies producing nothing and getting away with murder through ATMs. It’s a completely inefficient impotent sector permitted by corrupt and complicit @sec

$SGMO @SangamoTx Well, I sold today. 8 years ago, EIGHT long years, 2018 when I first entered Sangamo Been one long nightmare Somehow, someway I’ll find the strength to forgive myself and forgive Sandy Mccrae for running this company into the ground losing hard earned money

@BeerBubbelah @SangamoTx When relative volume increases but the price remains the same that is a sign of distribution or accumulation, and clearly it’s not accumulation, per the chart. And that’s exactly what’s happening. Even an idiot can see that

@trx0001 @SangamoTx You’re an idiot. You have zero proof about institutions unloading

$Sgmo I guess we’re reaching the end here, where the institutions are unloading on high volume without crashing the price. It seems close now, I don’t know when, but it feels like the end is very near now. What a shame @SangamoTx did to investors

@Steve72354669 @SangamoTx They still have time to do R/S. They have no respect for anyone’s time. They act like children always being late and silent. Company is full of 55 year old children @SangamoTx

@trx0001 @SangamoTx I thought for sure they would try and ram a RS down shareholders throats but now they do not even have time to get that done with a vote. I see no way they can get over a buck in the next 17 days. None.

$sgmo @SangamoTx But more than investors, Sangamo failed patients worldwide with Fabry disease Hemophilia A Hemophilia B Small fiber neuropathy Chronic neuropathic pain Renal transplantation (kidney transplant rejection) Sickle cell Beta thalasemmia MPS I &2 Huntington’s

@Steve72354669 @SangamoTx A greedy, sadistic coward

@trx0001 @SangamoTx The sad news is greedy scumbag could of had a deal long ago but his arrogance turned them down and now he has nothing.

@Steve72354669 @SangamoTx Cowards

@trx0001 @SangamoTx 17 days to being out of compliance and not a word at all from them. They I guess are going down without speaking which is just par for the course

$SGMO @SangamoTx Phenylketonuria (PKU) Huntington’s disease Prion disease Amyotrophic lateral sclerosis (ALS) Multiple sclerosis Inflammatory bowel disease All for naught with these thieves

@blackswantrader Not really sure God would approve much of the stock market. It’s been turned into a casino. Also, his will be done, not ours, Job suffered unimaginable pains and we could be dealt the same, I hope that is not the case but part of me thinks God is calling us to step away

$sgmo Divine help is on the way.

@Steve72354669 @SangamoTx Yes, please drop the news lying failure coward. We’re ready for the RS news chicken little.

@trx0001 @SangamoTx The thing is sandy is a coward so a Friday evening is a perfect time for him to drop it.

$sgmo $XBI @SangamoTx I think Monday we’ll receive the bad news and solidify the scam and failure that Sandy Maccrae and Sangamo have always been. Biotech is riddled with fraud. Reverse split Monday, someone stop the corruption

Could also release the bad news in a few hours too

@ericadamsfornyc Adams is like “ya’ll miss me, yet?”

No one should be surprised. After years of hateful rhetoric and incitement, attempts to justify attacks on Jews in Israel, praise for violence like the killing of a CEO, and chants about “globalizing the intifada” and “Death to America,” words have now escalated into violence on the streets of New York City, with explosives being thrown. We have a serious radicalization problem on both the far left and the far right, especially among young people. If we don’t confront it, this will only get worse. Thank you to the brave NYPD officers who once again ran toward danger and arrested the suspects.

@NYCMayor Whoa, we’re in trouble that this is the response from the Mayor on this situation. That’s a red alert kind of response

Yesterday, white supremacist Jake Lang organized a protest outside Gracie Mansion rooted in bigotry and racism. Such hate has no place in New York City. It is an affront to our city’s values and the unity that defines who we are. What followed was even more disturbing. Violence at a protest is never acceptable. The attempt to use an explosive device and hurt others is not only criminal, it is reprehensible and the antithesis of who we are. I want to thank the brave men and women of the NYPD who acted quickly to keep New Yorkers safe. Our officers ran toward danger without hesitation, demonstrating once again the courage and dedication it takes to protect this city every single day. My administration is closely monitoring the situation and I remain in close contact with our Police Commissioner.

@DHogweed @Franca_ole @Steve72354669 Seriously, you’re right. What is this guy talking about…it’s insane what he’s suggesting

@Franca_ole @Steve72354669 When your only bullish argument is “don’t worry: the company is able to massively dilute”, it’s a pretty good indicator that your investment sucks. And you suck, too.

The blanket assertion that $SGMO has produced nothing worthwhile is clearly inadequate and ignores essential facts. Anyone who takes a closer look at the company will quickly realize that Sangamo has built up substantial expertise in the field of gene editing over decades. In particular, the company's proprietary zinc finger technology is one of the best characterized and patented platforms in the field. Zinc finger nucleases (ZFNs) were one of the first precisely applicable gene editing technologies and remain an important basis for targeted genetic modifications today – with extensive intellectual property rights and industrial experience. In addition, Sangamo has broad patent portfolios that include not only classic gene editing but also regulatory systems and innovative platforms such as STAC-BBB (Systemic Targeted AAV Capsid), which aim to improve the crossing of the blood-brain barrier. This represents a highly relevant technological approach, particularly with regard to neurological diseases. In the field of epigenetic regulation and MINT-based gene modulation (Modular In Vivo Nuclease Technology), it is also clear that the research conducted here was by no means superficial, but rather built on long-term platform expertise. Another key point is the pipeline. With Isaralgagene civaparvovec (Isavec or ST-920) for the treatment of Fabry disease and Giroctocogene fitelparvovec for the treatment of hemophilia A, gene therapy programs are at an advanced stage, close to approval. In addition, there are other programs such as ST-503, which targets Nav1.7 as a target structure for pain therapies, and STN-506 in the field of prion diseases – both highly innovative and medically relevant indication areas with significant unmet needs. Of course, biotechnology is a high-risk field in which development times are long and setbacks are not uncommon. However, to conclude from this that a company has produced nothing worthwhile ignores both the technological substance and the clinical pipeline. Sangamo is a prime example of research-intensive platform biotechnology: with deep intellectual property, innovative approaches, and several clinically advanced programs. An objective assessment should take these aspects into account – instead of reducing complex scientific developments to undifferentiated blanket criticism.

@Franca_ole @Steve72354669 I reiterate “not a single product on the market” but you changed it to “has not produced anything worthwhile” which is a mischaracterization

$SGMO can issue up to 960 million of its common shares and up to 5 million preferred shares, for example for financing or partnership purposes – even though significantly fewer shares (approx. 370 million) are currently actually issued and in circulation. Delisting from stock exchange trading is not a realistic scenario!

@Steve72354669 @SangamoTx @SECGov With ongoing dead silence as per usual. Sickening

@trx0001 @SangamoTx @SECGov No idea how anyone can stick around working for that company they must buy his lies.

$SGMO @SangamoTx 30 years in business. Still not a single product on the market. Endless dilution & broken promises while shareholders pay the price. Either get acquired or shut it down. The Sangamo name doesn’t deserve to continue. Either cement your legacy in failure or speak

@Steve72354669 @SangamoTx @SECGov Or they’re in on it too. It’s just absurd at this point. The whole system is a corrupt joke

@Steve72354669 @SangamoTx This kind of behavior should never be permitted In the 10 years in the market @SECGov has done nothing to stop con artists like Sandy

@trx0001 @SangamoTx I am about ready to just sell out at this point and move on at a loss. I should have listened to people years ago saying sandy was a fraud. I really do see anything changing he will still be babbling about a partner in six months. He is a stone cold liar and con artist.